BRETYLIUM

SynDRA canonical compound SYN0022907 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · OTC
Primary target(s)	ATP1A1
Mechanism of action	norepinephrine inhibitor
Indication	ventricular arrhythmias \| ventricular fibrillation (VF) \| ventricular tachycardia (VT)
Disease area	cardiology

All known targets

bretylium tosilate
bretylan
bretylate
bretylium tosylate
Bretylium cation
Bretylium ion
Bretylum
Bretylium tolsylate
Bretylium tosylate(USAN)
N-(2-bromobenzyl)-N,N-dimethylethanaminium
N-ethyl-N,N-dimethyl-2-bromobenzenemethanaminium
Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1)
(2-bromobenzyl)ethyldimethylaminium
(2-bromophenyl)methyl-ethyl-dimethylazanium
(o-Bromobenzyl)ethyldimethylammonium p-toluenesulfonate
2-bromo-N-ethyl-N,N-dimethylbenzenemethanaminium
RZR75EQ2KJ
Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-
CHEBI:3172
[(2-bromophenyl)methyl](ethyl)dimethylazanium
((2-bromophenyl)methyl)(ethyl)dimethylazanium
RefChem:570223
DTXCID1026958
Bretylate
Bretylan
ASL 603
UNII-RZR75EQ2KJ
Prestwick1_000942
Prestwick2_000942
Prestwick3_000942
BRETYLIUM [VANDF]
BRETYLIUM [WHO-DD]
SCHEMBL15438
BSPBio_000904
SPBio_003063
BPBio1_000996
GTPL7130